Please login to the form below

Not currently logged in


This page shows the latest baxdrostat news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca to acquire CinCor Pharma in deal worth up to $1.8bn

AstraZeneca to acquire CinCor Pharma in deal worth up to $1.8bn

The deal will strengthen AZ’s cardiorenal pipeline through the addition of baxdrostat. ... CinCor will continue to hold the exclusive, worldwide licence to baxdrostat following the transaction.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts


Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

The speed of science and the pace of comms
Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......